Placido Polanco diagnosed with sports hernia

25 Comments

We might not see Placido Polanco back in the Phillies’ lineup for a while.

According to Jim Salisbury of CSNPhilly.com, Phillies general manager Ruben Amaro announced earlier this evening that Polanco was diagnosed with a sports hernia.

Polanco was sent back to Philadelphia over the weekend after revealing that he had been dealing with discomfort in his left hip for about a month. The veteran infielder is scheduled to receive an injection tomorrow and will be reevaulated on Friday. He has not been placed on the disabled list.

The Phillies haven’t ruled out surgery as a possibility, but it would not be a season-ending scenario. David Murphy of the Philadelphia Daily News reports that team doctors believe Polanco could recover within 3-4 weeks.

Polanco, 35, is hitting .275/.330/.342 with four home runs and 40 RBI over 383 plate appearances this season, but has a .223 batting average and .544 OPS since the start of May. With the Phillies well out in front in the National League East, they can afford to get by with the likes of Michael Martinez and Wilson Valdez at third base if it means Polanco will be healthy for the postseason.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.